- Home
- MMA vs XLO Comparison
MMA vs XLO Comparison
Compare MMA & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MMA
- XLO
- Stock Information
- Founded
- MMA 2013
- XLO 2016
- Country
- MMA Australia
- XLO United States
- Employees
- MMA N/A
- XLO N/A
- Industry
- MMA
- XLO Biotechnology: Pharmaceutical Preparations
- Sector
- MMA
- XLO Health Care
- Exchange
- MMA Nasdaq
- XLO Nasdaq
- Market Cap
- MMA 13.4M
- XLO 42.2M
- IPO Year
- MMA 2024
- XLO 2021
- Fundamental
- Price
- MMA $1.31
- XLO $0.69
- Analyst Decision
- MMA
- XLO Buy
- Analyst Count
- MMA 0
- XLO 1
- Target Price
- MMA N/A
- XLO $4.00
- AVG Volume (30 Days)
- MMA 464.9K
- XLO 625.2K
- Earning Date
- MMA 01-21-2025
- XLO 08-07-2025
- Dividend Yield
- MMA N/A
- XLO N/A
- EPS Growth
- MMA N/A
- XLO N/A
- EPS
- MMA N/A
- XLO N/A
- Revenue
- MMA $407,412.00
- XLO $9,274,000.00
- Revenue This Year
- MMA N/A
- XLO $300.08
- Revenue Next Year
- MMA N/A
- XLO $1.87
- P/E Ratio
- MMA N/A
- XLO N/A
- Revenue Growth
- MMA N/A
- XLO N/A
- 52 Week Low
- MMA $0.60
- XLO $0.62
- 52 Week High
- MMA $4.11
- XLO $1.70
- Technical
- Relative Strength Index (RSI)
- MMA N/A
- XLO 46.69
- Support Level
- MMA N/A
- XLO $0.66
- Resistance Level
- MMA N/A
- XLO $0.70
- Average True Range (ATR)
- MMA 0.00
- XLO 0.03
- MACD
- MMA 0.00
- XLO 0.01
- Stochastic Oscillator
- MMA 0.00
- XLO 81.13
About MMA Alta Global Group Limited
Mixed Martial Arts Group Ltd formerly Alta Global Group Ltd is a technology company engaged in the provision and administration of mixed martial arts training programs, and gym programs. It provides subscription-based products and services, offering both B2B SaaS solutions and B2C products and programs, covering online engagement, online content, and immersive in-gym experiences. The company's business units are; Trainalta.com; Mixed Martial Arts.com; and Hype.Co, Mobile Marketing solution. Its Alta Platform serves as a comprehensive solution for martial arts and combat sports, offering a blend of four core products: the Warrior Training Program, UFC Fight Fit Program, Alta Academy, and the Alta Community.
About XLO Xilio Therapeutics Inc.
Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).